In vitro safety evaluation of dopamine D₃R antagonist, R-VK4-116, as a potential medication for the treatment of opioid use disorder

• Rahul M. Nandre,

  Roles Data curation, Formal analysis, Investigation, Methodology, Project administration, Resources, Visualization, Writing – original draft

  Affiliation Therapeutic Development Branch, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institute of Health, Rockville, Maryland, United States of America

  https://orcid.org/0000-0002-0828-0970

  ⨯
• Amy Hauck Newman,

  Roles Conceptualization, Formal analysis, Resources, Writing – review & editing

  Affiliation Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse–Intramural Research Program, National Institute of Health, Baltimore, Maryland, United States of America

  ⨯
• Pramod S. Terse

  Roles Conceptualization, Formal analysis, Investigation, Project administration, Resources, Supervision, Visualization, Writing – review & editing

  * E-mail: tersep@mail.nih.gov

  Affiliation Therapeutic Development Branch, Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institute of Health, Rockville, Maryland, United States of America

  ⨯